𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human umbilical cord mesenchymal stem cells: Osteogenesis in vivo as seed cells for bone tissue engineering

✍ Scribed by Yinze Diao; Qingjun Ma; Fuzhai Cui; Yanfeng Zhong


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
965 KB
Volume
91A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Mesenchymal stem cells (MSCs) are ideal seed cells for bone tissue engineering. However, intrinsic deficiencies exist for the autologous transplantation strategy of constructing artificial bone with MSCs derived from bone marrow of patients. In this study, MSCs‐like cells were isolated from human umbilical cords and were expanded in vitro. Flow cytometric analysis revealed that cells from the fourth passage were positive for CD29, CD44, CD71, CD73, CD90, and CD105 whereas they were negative for CD14, CD34, CD45, and CD117. Furthermore, these cells expressed HLA‐A, B, C (MHC‐I), but not HLA‐DP, DQ, DR (MHC‐II), or costimulatory molecules such as CD80 and CD86. Following incubation in specific inductive media for 3 weeks, cultured cells were shown to possess potential to differentiate into adipogenic, osteogenic or chondrogenic lineages in vitro. The umbilical cord‐derived MSCs (UC‐MSCs) were loaded with a biomimetic artificial bone scaffold material before being implanted subcutaneously in the back of Balb/c nude mice for four to twelve weeks. Our results revealed that UC‐MSCs loaded with the scaffold displayed capacity of osteogenic differentiation leading to osteogenesis with human origin in vivo. As a readily available source of seed cells for bone tissue engineering, UC‐MSCs should have broad application prospects. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009


📜 SIMILAR VOLUMES


PLGA-chitosan/PLGA-alginate nanoparticle
✍ Qun Wang; Syed Jamal; Michael S. Detamore; Cory Berkland 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

## Abstract The natural polymers chitosan and alginate represent an attractive material choice for biodegradable inplants. These were used as coating materials to make positively and negatively charged PLGA nanoparticles, respectively. After blending at total solids concentration >10% wt/vol, these

In vivo magnetic resonance imaging track
✍ Sheng-Li Hu; Pei-Gang Lu; Li-Jun Zhang; Fei Li; Zhi Chen; Nan Wu; Hui Meng; Jian 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

## Abstract Human umbilical cord mesenchymal stem cells (hUC‐MSCs) can be efficiently labeled by superparamagnetic iron oxide (SPIO) nanoparticles, which produces low signal intensity on magnetic resonance imaging (MRI) in vitro. This study was to evaluate the feasibility of in vivo tracking for hU

Repair of bone defect with vascularized
✍ Mingdong Zhao; Jian Zhou; Xilei Li; Taolin Fang; Wenda Dai; Wangping Yin; Jian D 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 815 KB

## Abstract This study evaluated the results of repair of the radius defect with a vascularized tissue engineered bone graft composed by implanting mesenchymal stem cells (MSCs) and a vascular bundle into the xenogeneic deproteinized cancellous bone (XDCB) scaffold in a rabbit model. Sixty‐four rab

Enhancement of in vivo bone regeneration
✍ Jin Muk Kang; Sun-Woong Kang; Wan-Geun La; Yoon-Sun Yang; Byung-Soo Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract We hypothesized that bone morphogenetic protein‐2 (BMP‐2) would significantly enhance __in vivo__ bone formation efficacy of osteogenically undifferentiated human cord blood mesenchymal stem cells (hCBMSCs). To test this hypothesis, poly(lactic‐__co__‐glycolic acid)/hydroxyapatite (PLGA

Donor variation and loss of multipotency
✍ Ramakrishnaiah Siddappa; Ruud Licht; Clemens van Blitterswijk; Jan de Boer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 563 KB

## Abstract The use of multipotent human mesenchymal stem cells (hMSCs) for tissue engineering has been a subject of extensive research. The donor variation in growth, differentiation and in vivo bone forming ability of hMSCs is a bottleneck for standardization of therapeutic protocols. In this stu